Neuraxis (NRXS) officer converts 306K options, nets 193,678 shares
Rhea-AI Filing Summary
Neuraxis, INC (NRXS) reported insider equity compensation activity for officer Thomas Joeseph Carrico on 2026-08-24. Stock options for 306,236 shares were canceled and converted into an equivalent number of RSUs under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan, following approval by the board and stockholders. These RSUs vested immediately upon grant.
In a related event, 306,236 RSUs were granted and vested, and the company stated that, in connection with this vesting, 112,558 shares were withheld to satisfy income tax withholding and remittance obligations. After these events, 193,678 shares of common stock were acquired for the reporting person, bringing his directly held common stock position to 199,345 shares.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Buyer: 193,678 shares
Net Buy
4 txns
Insider
Carrico Thomas Joeseph
Role
CRO, CCO, CPO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Stock Options F2 | 306,236 | $6.94 | $2.13M |
| Grant/Award | RSU F2 | 306,236 | -- | -- |
| Conversion | RSU F2 | 306,236 | -- | -- |
| Grant/Award | Common Stock F1 | 193,678 | -- | -- |
Holdings After Transaction:
Stock Options — 0 shares (Direct);
RSU — 0 shares (Direct);
Common Stock — 199,345 shares (Direct)
Footnotes (2)
- F1. Reference is made to the 306,236 restricted stock units ("RSUs") granted and vested to the Reporting Person under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan as discussed below, of which 112,558 shares were withheld by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting of RSUs.
- F2. Following approval by the Company's Board of Directors and stockholders of the cancellation of stock options issued under the 2017 Innovative Health Solutions, Inc. Stock Compensation Plan and the grant of an equivalent number of RSUs under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan, the reporting person's stock options were canceled in exchange for an equivalent number of RSUs, which vested immediately upon grant.
Key Figures
Stock options canceled and converted: 306,236 options/RSUs
RSUs granted and vested: 306,236 RSUs
Shares withheld for taxes: 112,558 shares
+3 more
6 metrics
Stock options canceled and converted
306,236 options/RSUs
Stock options canceled and converted into an equivalent number of RSUs on 2026-08-24
RSUs granted and vested
306,236 RSUs
RSUs granted and vested under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan
Shares withheld for taxes
112,558 shares
Shares withheld to satisfy income tax withholding and remittance obligations upon RSU vesting
Common stock acquired
193,678 shares
Shares of common stock acquired in connection with RSU vesting on 2026-08-24
Common stock held after transactions
199,345 shares
Directly owned Neuraxis, INC common stock position after the reported transactions
Derivative conversion price
$6.94 per option
Reported price associated with the 306,236 stock options converted to RSUs
Key Terms
restricted stock units, RSUs, income tax withholding and remittance obligations, Omnibus Securities and Incentive Plan, +1 more
5 terms
restricted stock units financial
"Reference is made to the 306,236 restricted stock units ("RSUs") granted and vested"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"306,236 restricted stock units ("RSUs") granted and vested to the Reporting Person"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
income tax withholding and remittance obligations financial
"shares were withheld by the Issuer to satisfy income tax withholding and remittance obligations"
Omnibus Securities and Incentive Plan financial
"under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan"
Conversion of derivative security financial
"transaction_code_description": "Conversion of derivative security""
FAQ
What insider equity transactions did NRXS report for Thomas Joeseph Carrico on 2026-08-24?
On 2026-08-24, Neuraxis, INC reported that 306,236 stock options were canceled and converted into 306,236 RSUs, which vested immediately, and that 193,678 shares of common stock were acquired for the reporting person, subject to tax withholding.
How many Neuraxis (NRXS) stock options were canceled and converted to RSUs?
The reporting person had 306,236 stock options canceled in exchange for an equivalent 306,236 RSUs under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan, as approved by the company’s board of directors and stockholders.
What is Thomas Joeseph Carrico’s resulting NRXS common stock holding after these transactions?
Following the reported transactions on 2026-08-24, the reporting person directly held 199,345 shares of Neuraxis, INC common stock, as disclosed in the Form 4 data.
Were the Neuraxis (NRXS) RSUs from this filing immediately vested?
Yes. The company disclosed that the 306,236 RSUs granted in exchange for canceled stock options under the 2022 Omnibus Securities and Incentive Plan vested immediately upon grant following board and stockholder approval.
AI-generated analysis. How Rhea-AI works. Not financial advice.
